XML 52 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Instruments
12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments

Note 4. Financial Instruments

The following table summarizes the amortized cost and fair value of available-for-sale securities at December 31, 2022 and 2021 (in thousands):

 

 

 

Amortized
Cost/Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair Value

 

At December 31, 2022:

 

 

 

 

 

 

 

 

 

 

 

 

Money market fund

 

$

57,799

 

 

$

 

 

$

 

 

$

57,799

 

U.S. government agency securities and treasuries

 

 

206,520

 

 

 

13

 

 

 

(162

)

 

 

206,371

 

Total

 

$

264,319

 

 

$

13

 

 

$

(162

)

 

$

264,170

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2021:

 

 

 

 

 

 

 

 

 

 

 

 

Money market fund

 

$

176,102

 

 

$

 

 

$

 

 

$

176,102

 

Total

 

$

176,102

 

 

$

 

 

$

 

 

$

176,102

 

 

No available-for-sale debt securities held as of December 31, 2022 and 2021 had remaining maturities greater than one year. Unrealized gains and losses on available-for-sale securities are included as a component of comprehensive loss. At December 31, 2022, the Company did not have any securities in material unrealized loss positions.

The Company reviews its investments to identify and evaluate investments that have an indication of possible other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include the length of time and extent to which fair value has been less than the cost basis, the financial condition and near-term prospects of the investee, and the Company’s intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value. The Company does not generally sell any investments prior to recovery of their amortized cost basis for any investments in an unrealized loss position.